Gene Patenting
A recent US Supreme Court ruling found that companies cannot patent things found in nature. Peter Day asks what this means for the biotech business.
Ever since the mapping of the human genome was completed 10 years ago medical companies have been rushing to patent genes that define all of us for their own exclusive use. Now the US Supreme Court has ruled against patenting things found in nature. Peter Day asks what this means for the biotech business.and for the future of healthcare.
Last on
Contributors to this programme
Professor Sir John Burn
Professor of Clinical Genetics, Institute of Genetic Medicine Newcastle University
Μύ
Μύ
David Koepsell
Author, Who Owns You?
ΜύJulian Hitchcock
Life Science Lawyer, Lawford Davies Denoon
ΜύDr Michael Hopkins
Senior Lecturer, University of Sussex
ΜύDr Berwyn Clarke
Entrepreneur
ΜύDr Hani Gabra
Professor of Medical Oncology, Imperial College London
ΜύDr Helen Wallace
Director Genewatch UK
ΜύDr Stuart Hogarth
Research Fellow, Kings College London
Μύ
Μύ
Μύ
Broadcasts
- Thu 8 Aug 2013 20:30Βι¶ΉΤΌΕΔ Radio 4
- Sun 11 Aug 2013 21:30Βι¶ΉΤΌΕΔ Radio 4
Download this programme
Subscribe to this programme or download individual episodes.